Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
General Physiology and Biophysics Vol.28, No.3, p.294–301, 2009 |
||
Title: Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha | ||
Author: Daniela Krejčová, Jiřina Procházková, Lukáš Kubala and Jiří Pacherník | ||
Abstract: Treatments of non-small cell lung cancer (NSCLC), the most common form of lung cancer, still remain poor. Interferon alpha (IFN-α), an important physiological immunomodulator, possesses direct cytotoxic and cytostatic effects on tumour cells, antiangiogenic effects, and activates anti-tumour immunity. Recently, the IFN-α oncologic indications have included melanoma, renal carcinoma, and different types of leukaemia. However, the application of IFN-α in therapy of lung cancer has not been validated yet. Herein the human lung carcinoma cell line A549, a model of NSCLC in vitro, was used to pursue the effect of IFN-α on A549 cell proliferation and differentiation together with the effect on protein expression and activity of three ATP-transporters mediating multi-drug resistance (MDR). IFN-α significantly inhibited the proliferation of A549 cells which was not connected with arrest in a particular cell cycle phase. Further, IFN-α-mediated differentiation of A549 was observed based on an increase in alkaline phosphatase activity. Simultaneously, IFN-α increased the expression and activity of ATP-transporters mediating MDR. Thus, the IFN-α down-regulation of NSCLC cell proliferation was accompanied by a potential of cells to exclude potential therapeutic substances such as chemotherapeutic agents. These effects could have a significant impact on considerations of IFN-α as a therapeutic agent for NSCLC. |
||
Keywords: Non-small cell lung cancer — ABC transporter proteins — Cell cycle — Interferons | ||
Year: 2009, Volume: 28, Issue: 3 | Page From: 294, Page To: 301 | |
doi:10.4149/gpb_2009_03_294 |
||
|
download file |
|